Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases 2024-02-27 01:06
OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED - HIGHLIGHTING NATIONAL GENDER PAIN GAP 2024-02-26 21:01
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization 2024-02-26 21:00
Encouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-02-26 14:37
Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care 2024-02-26 10:10
Siriraj Hospital Expands Services to Provide Advanced Medical Care, Highlights State-of-the-Art Technology for Cancer Treatment 2024-02-26 08:00
Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research 2024-02-26 06:00
Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies 2024-02-23 18:23
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy 2024-02-23 15:00
Kakao Brain Debuts 'KARA-CXR', a Web-Based Radiology Report Service Powered by Large-Scale AI 2024-02-22 21:00
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline 2024-02-22 17:31
Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis 2024-02-22 08:59
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro 2024-02-21 16:00
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA 2024-02-21 12:26
Everest Medicines' Licensing Partner Venatorx Pharmaceuticals Announces Publication of Positive Results from Cefepime-Taniborbactam's Phase 3 CERTAIN-1 Study in New England Journal of Medicine 2024-02-21 09:00
Datasea Establishes Joint Venture Company to Further Penetrate the Estimated Approximately 527.8 billion US Dollars 5G Market in China 2024-02-21 01:31
MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment 2024-02-20 14:00
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA 2024-02-20 08:22
HKUST Neuroscientists Develop Highly Accurate Universal Diagnostic Blood Test for Alzheimer's Disease and Mild Cognitive Impairment 2024-02-19 20:18
SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 2024-02-19 10:55
1 53 54 55 56 57 531